Skip to main content
Fig. 3 | BMC Psychiatry

Fig. 3

From: Hypnotic prescription trends and patterns for the treatment of insomnia in Japan: analysis of a nationwide Japanese claims database

Fig. 3

Distribution of hypnotics segmented by psychiatric comorbidities and age (a) and sex (b) among new users of hypnotics. The distributions of hypnotics prescribed to new users of hypnotics in 2018–2019 were segmented according to psychiatric comorbidities × age (a) and psychiatric comorbidities × sex (b). Values are % of patients. Neurocognitive disorders = Alzheimer’s disease. BZD benzodiazepine, MOA mechanism of action, MRA melatonin receptor agonist, ORA orexin receptor antagonist, z-drug non-benzodiazepine

Back to article page

BMC Psychiatry

ISSN: 1471-244X

Contact us